Regulatory Post Marketing Surveillance of Intelence Tablet

Trial Profile

Regulatory Post Marketing Surveillance of Intelence Tablet

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2015

At a glance

  • Drugs Etravirine (Primary)
  • Indications Acquired immunodeficiency syndrome
  • Focus Adverse reactions
  • Sponsors Janssen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Sep 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
    • 11 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top